Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer

Triple-negative breast cancer (TNBC) refers to a group of biologically aggressive breast cancers that do not express estrogen, progesterone or epidermal growth factor receptor 2 hormone receptors. Each subset of TNBC has a unique molecular profile and may require specific treatments. A combination o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mast, Jesse M., Kuppusamy, Periannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256245/
https://www.ncbi.nlm.nih.gov/pubmed/30524959
http://dx.doi.org/10.3389/fonc.2018.00527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256245/
https://www.ncbi.nlm.nih.gov/pubmed/30524959
http://dx.doi.org/10.3389/fonc.2018.00527

Ejemplares similares